Cargando…

PPARγ Ligand as a Promising Candidate for Colorectal Cancer Chemoprevention: A Pilot Study

Activating synthetic ligands for peroxisome proliferator-activated receptor gamma (PPARγ), such as pioglitazone, are commonly used to treat persons with diabetes mellitus with improvement of insulin resistance. Several reports have clearly demonstrated that PPARγ ligands could inhibit colorectal can...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takahashi, Hirokazu, Hosono, Kunihiro, Uchiyama, Takashi, Sugiyama, Michiko, Sakai, Eiji, Endo, Hiroki, Maeda, Shin, Schaefer, Katherine L., Nakagama, Hitoshi, Nakajima, Atsushi
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2010
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2929500/ https://www.ncbi.nlm.nih.gov/pubmed/20814432 http://dx.doi.org/10.1155/2010/257835

Ejemplares similares

Eicosapentaenoic acid (EPA) efficacy for colorectal aberrant crypt foci (ACF): a double-blind randomized controlled trial
por: Higurashi, Takuma, et al.
Publicado: (2012)

PPARγ: The Portrait of a Target Ally to Cancer Chemopreventive Agents
por: Sainis, Ioannis, et al.
Publicado: (2008)

Capsule endoscopy with flexible spectral imaging color enhancement reduces the bile pigment effect and improves the detectability of small bowel lesions
por: Sakai, Eiji, et al.
Publicado: (2012)

Chemoprevention of colorectal cancer: Past, present, and future
por: Umezawa, Shotaro, et al.
Publicado: (2019)

PPAR Ligands for Cancer Chemoprevention
por: Yasui, Yumiko, et al.
Publicado: (2008)

Antiangiogenic Phytochemicals Constituent of Diet as Promising Candidates for Chemoprevention of Cancer
por: Marrero, Ana Dácil, et al.
Publicado: (2022)

Development of PPARγ Agonists for the Treatment of Neuroinflammatory and Neurodegenerative Diseases: Leriglitazone as a Promising Candidate
por: Pizcueta, Pilar, et al.
Publicado: (2023)

Metformin efficacy and safety for colorectal polyps: a double-blind randomized controlled trial
por: Higurashi, Takuma, et al.
Publicado: (2012)

The Promise of Piperine in Cancer Chemoprevention
por: Benayad, Salma, et al.
Publicado: (2023)

Change of Gastric Emptying With Chewing Gum: Evaluation Using a Continuous Real-Time (13)C Breath Test (BreathID System)
por: Sakamoto, Yasunari, et al.
Publicado: (2011)

Promising agents for chemoprevention of skin cancer
por: Stratton, S.P., et al.
Publicado: (2006)

PPARγ Inhibitors as Novel Tubulin-Targeting Agents
por: Schaefer, Katherine L.
Publicado: (2008)

Alteration of PPAR‐GAMMA (PPARG; PPARγ) and PTEN gene expression in acute myeloid leukemia patients and the promising anticancer effects of PPARγ stimulation using pioglitazone on AML cells
por: Esmaeili, Shadi, et al.
Publicado: (2021)

Mosapride Accelerates the Delayed Gastric Emptying of High-Viscosity Liquids: A Crossover Study Using Continuous Real-Time (13)C Breath Test (BreathID System)
por: Sakamoto, Yasunari, et al.
Publicado: (2011)

Early Effect of Single-dose Sitagliptin Administration on Gastric Emptying: Crossover Study Using the (13)C Breath Test
por: Nonaka, Takashi, et al.
Publicado: (2013)

Fisetin and Quercetin: Promising Flavonoids with Chemopreventive Potential
por: Kashyap, Dharambir, et al.
Publicado: (2019)

PPARγ in Neuroblastoma
por: Peri, Alessandro, et al.
Publicado: (2008)

Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases
por: Kulkarni, Ajit A., et al.
Publicado: (2012)

Effects of Histamine-2 Receptor Antagonists and Proton Pump Inhibitors on the Rate of Gastric Emptying: A Crossover Study Using a Continuous Real-Time (13)C Breath Test (BreathID System)
por: Nonaka, Takashi, et al.
Publicado: (2011)

Zinc: A promising agent in dietary chemoprevention of cancer
por: Dhawan, D. K., et al.
Publicado: (2010)

Plant Natural Products: Promising Resources for Cancer Chemoprevention
por: Ma, Li, et al.
Publicado: (2021)

The Roles of Dietary PPARγ Ligands for Metastasis in Colorectal Cancer
por: Kuniyasu, Hiroki
Publicado: (2008)

Pharmacological Treatment of Chemotherapy-Induced Neuropathic Pain: PPARγ Agonists as a Promising Tool
por: Quintão, Nara Lins Meira, et al.
Publicado: (2019)

PPARγ and Apoptosis in Cancer
por: Elrod, Heath A., et al.
Publicado: (2008)

PPARγ, neuroinflammation, and disease
por: Mrak, Robert E, et al.
Publicado: (2004)

Nutraceuticals as Ligands of PPARγ
por: Penumetcha, Meera, et al.
Publicado: (2012)

PPARγ and Cognitive Performance
por: d’Angelo, Michele, et al.
Publicado: (2019)

Metformin- A Promising Agent for Chemoprevention in BRCA1 Carriers
por: Kumar, Nagi B., et al.
Publicado: (2012)

Promising Compounds From Murraya exotica for Cancer Metastasis Chemoprevention
por: He, Su-Dan, et al.
Publicado: (2016)

Lipoprotein Lipase as a Candidate Target for Cancer Prevention/Therapy
por: Takasu, Shinji, et al.
Publicado: (2012)

The Gold(I) Complex with Plant Hormone Kinetin Shows Promising In Vitro Anticancer and PPARγ Properties
por: Trávníček, Zdeněk, et al.
Publicado: (2023)

Phosphorylation of PPARγ Affects the Collective Motions of the PPARγ-RXRα-DNA Complex
por: Lemkul, Justin A., et al.
Publicado: (2015)

PPARγ and PPARδ as Modulators of Neoplasia and Cell Fate
por: Glazer, Robert I., et al.
Publicado: (2008)

Pharmacological (or Synthetic) and Nutritional Agonists of PPAR-γ as Candidates for Cytokine Storm Modulation in COVID-19 Disease
por: Ciavarella, Carmen, et al.
Publicado: (2020)

Comparative Gene Expression Profiles Induced by PPARγ and PPARα/γ Agonists in Human Hepatocytes
por: Rogue, Alexandra, et al.
Publicado: (2011)

Structural basis for PPARγ transactivation by endocrine-disrupting organotin compounds
por: Harada, Shusaku, et al.
Publicado: (2015)

Scaffold-Based Pan-Agonist Design for the PPARα, PPARβ and PPARγ Receptors
por: Zhang, Li-Song, et al.
Publicado: (2012)

Franseen Needles May Be Promising for Improving the Sampling Adequacy of EUS-FNA for Subepithelial Lesions
por: Kasuga, Noriki, et al.
Publicado: (2022)

Perspective: Chemoprevention of colorectal neoplasia: Translating scientific promise into clinical practice
por: Lance, Peter, et al.
Publicado: (2011)

Emergence of aspirin as a promising chemopreventive and chemotherapeutic agent for liver cancer
por: Xia, Hongping, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vjbnv568ebi7p2m9hbijlqjjqq